Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
6.97
-0.34 (-4.65%)
At close: Oct 30, 2026, 4:00 PM EST
6.95
-0.02 (-0.29%)
After-hours: Oct 30, 2026, 6:52 PM EST

Ocular Therapeutix Revenue

Ocular Therapeutix had revenue of $13.48M in the quarter ending June 30, 2026, with 0.12% growth. This brings the company's total for the last twelve months to $52.05M, down -8.14% year-over-year. In the year 2025, Ocular Therapeutix had annual revenue of $51.95M, down -18.47%. That makes Ocular Therapeutix the 27,703rd largest company in the world by revenue and 3,763rd in the United States.

Revenue (ttm)
$52.05M
Revenue Growth
-8.14%
P/S Ratio
29.41
Revenue / Employee
$160,169
Employees
325
Market Cap
1.53B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202551.95M-11.77M-18.47%
Dec 31, 202463.72M5.28M9.03%
Dec 31, 202358.44M6.95M13.49%
Dec 31, 202251.49M7.97M18.32%
Dec 31, 202143.52M26.12M150.08%
Dec 31, 202017.40M13.18M311.71%
Dec 31, 20194.23M2.24M112.41%
Dec 31, 20181.99M67.00K3.48%
Dec 31, 20171.92M36.00K1.91%
Dec 31, 20161.89M137.00K7.83%
Dec 31, 20151.75M978.00K126.68%
Dec 31, 2014772.00K--
Dec 31, 2013---
Dec 31, 201210.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ultragenyx Pharmaceutical717.00M
Innoviva440.00M
Immunocore Holdings430.78M
UroGen Pharma188.73M
Nuvation Bio169.90M
AnaptysBio106.09M
Nanobiotix13.15M
Lycia Therapeutics4.44M
Revenue Rankings